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Abstract
Objectives: Congestive heart failure (CHF) is the most common cause of 30-day inpatient readmission. Studies have
found that early follow-up with primary care physicians (PCP) within 7 days of discharge may improve 30-day readmission
rates; however, many have used a multidisciplinary discharge coordination team, which is not a resource at all centers.
Here, the authors present a resident-driven quality improvement initiative using a monthly quality and safety award to
increase early PCP follow-up for veterans discharged following admissions due to a CHF exacerbation. Primary outcomes
were percentage of PCP follow-up within 7 days and median time to PCP follow-up. Secondary outcomes included
percentage of patients attending a PCP visit within 7 days, 30-day readmission, and 30-day mortality.
Methods: This prepost quasi-experimental cohort study evaluated 3 concurrent quality improvement interventions to
increase PCP follow-up after CHF exacerbation. Process maps and Ishikawa diagrams examined the discharge process.
Interventions included a standardized discharge scheduling order, monthly education on the process, and monthly
aggregated performance feedback for each medical resident. A patient safety and quality award was given to the team
with the highest rate of PCP appointments scheduled within 7 days. Patient characteristics and outcomes were gathered
for a 6-month historic period and 6-month intervention period. Test of proportions and Wilcoxon Rank-Sum test were
used to compare groups.
Results: A total of 294 patients were discharged (161 in historic group and 133 in intervention group). Appointments
scheduled within 7 days of discharge increased from 43% to 79% (P < 0.001). Median time to PCP follow-up decreased
from 8 to 6 days (P < 0.001). Patients who completed (showed up to) a PCP appointment within 7 days increased
from 16% to 41% (P < 0.001). There was no impact on 30-day readmission or mortality; however, the number of study
subjects was too small to rule out an effect.
Conclusions: A standardized discharge scheduling order, more robust resident education, and a monthly patient safety
and quality award resulted in a significant increase in the rate of primary care follow-up within 7 days of CHF exacerbation.
Keywords
congestive heart failure exacerbation, quality improvement, resident driven

Congestive heart failure (CHF) contributes to over $17
billion in Medicare expenditures and over a million
annual hospital admissions in the United States.1 The
American Heart Association projects that the costs
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associated with CHF care will more than double from
$307 billion annually to $697 billion by the year 2030.2
Efforts to reduce costs and prevent morbidity associated with CHF have focused on reducing the 30-day
readmission rates, which remain above 20%.2–4 In
2012, the Hospital Readmission Reduction Program
was passed as an effort to reduce 30-day CHF readmissions in addition to other diagnoses with high prevalence among Medicare beneficiaries. Under this
program, if a hospital’s readmission rate for CHF is
above the national average by a predetermined percentage, the hospital suffers reductions in reimbursement
by the Centers for Medicare and Medicaid Services.5,6
Transition of care services such as timely outpatient
follow-up with primary care physicians (PCP) within 1
week after discharge for CHF have been proposed as a
mechanism to reduce readmissions and thus avoid such
penalties while improving the quality of patient care.7–9

2
Within the Veterans health administration (VA) system,
PCP follow-up within 7 days of discharge is tracked
nationally as a CHF quality metric. The arrangement of
postdischarge appointments within a short-time frame
often poses a scheduling and logistical challenge. Prior
published quality improvement (QI) efforts to increase
PCP follow-up after CHF exacerbation have been successful; however, many have used a multidisciplinary
team including physicians, nurses, and clinical pharmacists.9–14 In centers without robust clinical pharmacy
services or nurses dedicated to placing orders on behalf
of physicians to assist in transition of care coordination, the timing, and logistics of follow-up after discharge falls on the discharging physician. The primary
outcomes of this project were the percentage of PCP
follow-up appointments arranged within 7 days of discharge and median time to PCP follow-up for patients
discharged due to CHF exacerbation. The primary QI
aim was to increase the percentage of patients with
PCP appointments within 7 days by 20% from baseline
within 6 months. Secondary outcomes included the
percentage of 7-day follow-up completion rate, 30-day
all-cause readmission rate, and 30-day mortality rate.

Methods

Setting
The John D. Dingell Veterans Affairs Medical Center
is a 267-bed acute-care teaching hospital in Detroit,
Michigan. Heart failure readmission rates at the John
D. Dingell VA Medical Center were higher than the
national average. The 30-day all-cause readmission
rate for CHF exacerbation at the start of this project
in 2018 was 27% (compared with the national average around that time period of 21%–23%).5,15

Process Evaluation
This quasi-experimental cohort study was designed
to increase the proportion of primary care follow-up
within 7 days for patients discharged with CHF exacerbation using a resident-driven model and monthly
quality and safety award. A historic 6-month cohort
of patients discharged for CHF exacerbation from
September 1, 2018, to February 28, 2019, was compared with an intervention cohort of patients discharged for the same reason between September 1,
2019, and February 29, 2020. Before the intervention, the local practice was for chief residents to
instruct all medical residents to request PCP appointments within 7 days of discharge for CHF exacerbation patients; however, no instruction on how to do
so was provided. The intervention started with a
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process evaluation conducted by the Chief Resident
in Quality and Safety (CRQS), a medical doctor graduate in internal medicine pursuing an additional postdoctoral year with a focus on quality and safety
education. During the process evaluation, the CRQS
conducted informal focus groups with residents on
the wards who were placing discharge orders and
also met with ward scheduling clerks who were
responsible for making follow-up appointments. A
process map of the series of steps from discharge to
primary care follow-up was then developed. The process map revealed numerous issues in the discharge
process. First, whether the patient was scheduled to
see a PCP, a cardiologist, or both after discharge varied widely. Second, the decision on when to request
outpatient follow-up was not standardized, with
some teams making the requests shortly after admission to try to stream-line the process, while others
waited until the day of discharge to ensure that the
patient would not still being in the hospital during
their future appointment time. Third, despite basic
instruction that appointments should be within 7
days of discharge, the requested time to follow-up
varied among different teams (eg, 1–2 weeks for
some, or simply no timeframe requested for others).
Fourth, residents were using a variety of strategies to
obtain follow-up for their patients, including direct
calls to nurse discharge coordinators who stated they
were unable to place orders, placing “scheduling”
orders for a floor clerk to call and make the appointment, and placing outpatient consult orders directly
to various clinics including some which were incorrect. If a patient was discharged during a holiday,
weekend, or evening, the process was even less clear.
Finally, an Ishikawa (fishbone) diagram, constructed
using the previously found difficulties, also revealed
multiple system-based issues in the discharge process,
including limited appointment availability and lack
of a standardized mechanism for scheduling clerks to
know when a discharge was related to CHF and thus
time sensitive.

Intervention Description
After meetings and discussion with ward clerks and
medical residents, a standardized workflow process
and scheduling order for requesting PCP follow-up
visits was created. The first step was educating medical residents on this ordering process during their
monthly education, including step-by-step screen
shots of how to enter the orders and instruction to
do so early, ideally within 24 hours of admission.
Residents were also given contingency plans for
nights, weekends, or situations in which an
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appointment was requested later than ideal such as
on the day of discharge. The CRQS educated all residents rotating on and off the wards each month to
orient them to this process. In addition, the CRQS in
conjunction with the hospital Chief of Staff initiated
a monthly “Patient Safety and Quality Award” for
the internal medicine team with the highest rate of
PCP follow-up appointments scheduled within 7
days of discharge for their CHF patients. The award
was printed on cardstock and given during noon lecture at the end of each month as an incentive and
motivational tool. After Plan, Do, Study, Act (PDSA)
cycle 1, data showed an increase in the percentage of
CHF patients for whom a PCP follow-up had been
ordered; however, there were numerous instances
where the appointment had not been scheduled
within 7 days as requested (Figure 1). During PDSA
cycle 2, other stake holders such as scheduling clerk
supervisors and the ambulatory physician section
chief were involved and asked for more input on the
process. Additional training was provided to ward
clerks on how to prioritize scheduling for CHF
patients, and a contingency plan was adopted that
included immediate escalation to the chief scheduling nurse and ambulatory physician section chief via
email if no appointments within 7 days were
available.

Data Collection and Analysis
Data on time to PCP follow-up, follow-up completion, and all-cause 30-day readmission rates were
assessed via retrospective chart review of patients
with CHF exacerbation who were discharged during
the historic and intervention periods. Age and other
clinical characteristics relating to degree of illness and
comorbidities pertinent to CHF were also collected
and compared between groups. Data on discharged
patients were extracted from a VA Regional Data
Warehouse for manual analysis. The primary outcomes were the percentage of PCP follow-up appointments scheduled within 7 days of discharge and the
median time to PCP follow-up. Secondary outcomes
included the percentage of 7-day follow-up appointments completed by patients (defined as the patient
being scheduled and showing up for the appointment), 30-day all-cause readmission, and 30-day
mortality rate. Categorical and continuous nonparametric data in the 2 groups were compared with a test
of difference in proportions, or Wilcoxon Rank-Sum
test as appropriate. Data were analyzed using STATA
Version 16.1. The project was deemed to represent
QI and exempt from institutional board review
approval.

Results
A total of 294 patients were included in the study
(161 in the historic group, and 133 in the intervention group). Median (interquartile [IQR]) age was 70
(63.3–76) years and primarily (98%) male with high
rates of cardiopulmonary comorbidities and hospitalization within the preceding year (Table 1).
Demographic data and clinical characteristics were
similar between groups (Table 1). The primary outcome of percentage of PCP follow-up appointments
arranged within 7 days increased from 42.9% in the
historic group to 78.9% in the intervention group
(P < 0.001). The median (IQR) time to follow-up
decreased from 8 (5–15) to 6 (4–7) days (P < 0.001)
(Table 2). A control chart of median time to followup with split control limits before and after the QI
intervention is shown in Figure 2. The percentage of
patients who completed a PCP appointment within 7
days also increased from 16.1% to 40.6%
(P < 0.001). All-cause 30-day readmissions did not
differ between the groups, at 27.3% in the historic
group, and 21.8% in the intervention group. However,
using an alpha of 0.05 and power of 80%, the
required sample size would have had to have been
around 1920 patients to reach a statistically significant difference in readmissions at these incidence
rates. Similarly, 30-day mortality was underpowered
to an even greater extent. In a subgroup analysis of
patients in the intervention group, those who received
an appointment within 7 days had similar rates of
readmission to those who did not (P = 0.616).
Additionally, those who attended their 7-day PCP
appointment had similar rates of readmission to
those who did not (P = 0.136).

Discussion
The primary aim of this project was to achieve a 20%
increase from baseline in the percentage of patients
discharged due to CHF exacerbation who had PCP
follow-up within 7 days. This primary aim was met,
and the authors were able to significantly reduce
median time to follow-up. In addition, the percentage
of patients who actually attended their 7-day followup appointments also increased. The process evaluation helped engage system stakeholders and gain
further insight into the complexity and shortcomings
of the discharge appointment scheduling process.
Unfortunately, 30-day readmission and mortality
were not ultimately reduced; however, the number of
patients in the study was too small for it to have a
reasonable chance of reaching a statistically significant difference in readmissions or mortality. Other
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Figure 1. Rolling Deming (PDSA) cycle design used during 6-month intervention period.

studies have conducted similar interventions among
discharging medical residents to increase primary
care follow-up; however, none were without utilization of some type of multidisciplinary team including
clinical pharmacists or nurse discharge coordinators.11–14 To date, no other QI studies have been conducted among medical residents using creation of an
award as a motivational tool and reward strategy.
Strengths of this project include this unique aspect as

well as its relative simplicity. Once the process evaluation was completed and a plan was in place, the
intervention itself involved more robust resident education and a monthly patient safety and quality
award; neither of which had any monetary cost to the
institution. Although education is considered a weak
intervention in the QI community, the monthly orientation of house staff starting their rotation at the VA
was already a standardized process, which made this

Table 1. Demographic and Clinical Characteristics of Patients Discharged Due to Congestive Heart Failure Exacerbation
Characteristic

Total, n = 294

Historic group, n = 161

Age median (IQR), years
Male, n (%)
EF%, median (IQR)
EF <30%, n (%)
Atrial fibrillation, n (%)
Coronary artery disease, n (%)
COPD, n (%)
Chronic kidney disease, n (%)
Diabetes, n (%)
Hospitalizations in last 1 year, median (IQR)

70 (63.3–76)
288 (98.0)
35 (20–55)
108 (36.7)
117 (39.8)
147 (50.0)
122 (41.5)
118 (40.1)
139 (47.3)
2 (1–4)

70 (63–76)
156 (96.9)
35 (20–55)
63 (39.1)
62 (38.5)
79 (49.1)
62 (38.5)
68 (42.2)
73 (45.3)
2 (1–4)

Abbreviations: COPD, chronic obstructive pulmonary disease; EF, ejection fraction; IQR, interquartile range.

Intervention group, n = 133
70 (64–75.8)
132 (99.2)
37 (20–55)
45 (33.8)
55 (41.4)
68 (51.1)
60 (45.1)
50 (37.6)
66 (49.6)
2 (1–4)

P
0.562
0.155
0.522
0.349
0.815
0.725
0.253
0.483
0.464
0.621
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Table 2. Primary Care Follow-up and Other Outcomes for Patient Discharged Due to Congestive Heart Failure Exacerbation

Primary outcomes
PCP appointment scheduled within 7 days of DC, n (%)
Time to PCP Follow-up, median (IQR), days
Secondary outcomes
Patient attended PCP appointment within 7 days of DC, n (%)
30-day readmission, n (%)
30-day mortality, n (%)

Total
n = 294

Historic Group
n = 161

Intervention Group
n = 133

P

174 (59.2)
7 (4–11)

69 (42.9)
8 (5–15)

105 (78.9)
6 (4–7)

<0.001
<0.001

80 (27.2)
73 (24.8)
1 (1.4)

26 (16.1)
44 (27.3)
3 (1.9)

54 (40.6)
29 (21.8)
1 (0.8)

< 0.001
0.275
0.413

DC, discharge; IQR, interquartile range; PCP, primary care physician;.

easy to adapt and maintain. Use of a scheduling order
through the electronic medical record standardized
the process and removed the extra work for residents
such as phone calls or face-to-face meetings with
clerks. Most importantly, this intervention did not
require any additional discharge coordination staff
such as clinical pharmacists, nurses, or mid-level providers and would be feasible to adopt in settings
without those extra staff resources. Limitations of
this project include the almost exclusively male
patient population, which may be hard to generalize
to other centers caring for a mix of male and female
CHF patients. As trainees, medical residents may
have been more influenced by an award from an
upper-level hospital administrator and thus this intervention may be less successful in nonacademic

settings. If applied to centers where discharging physicians are fully credentialed employed hospitalists or
internists, a similar reward from a leader in the medical division may still be a successful intervention
strategy, especially if tied to financial bonus. Finally,
the monthly tracking of discharge appointment metrics down to the level of individual physician data
was performed by the CRQS and may not be possible
in a system utilizing less detailed manual data abstraction techniques. It is notable that although 78.9% of
patients in the intervention period left the hospital
with a primary care appointment within 7 days, only
40.1% were physically seen by their PCP within 7
days. All discharged patients receive a paper copy of
their discharge summary containing the dates, times,
and location of scheduled future appointments. In

Figure 2. Control chart for time to primary care follow-up before and after a quality improvement intervention
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addition, clinic staff provide a reminder call in the
24–48 hours before the visit. The study population
was comprised of elderly men of color who were hospitalized in inner city Detroit, so there may have been
transportation or other social determinants of health
which impeded appointment attendance. Although
veterans without reliable transportation have access
to vouchers, low health literacy may limit patient
ability to navigate and obtain such resources. This
study was for QI purposes and did not involve direct
contact with individual patients to see why they did
not attend their appointment, therefore the exact
cause of these missed appointments are not clear.
Overall, increasing the attendance at PCP visits after
discharge for CHF exacerbation did not reduce readmissions, even in a subgroup analysis of intervention
patients who came to their appointments. Other studies have found that close follow-up after discharge is
beneficial. For example, in nearly 12,000 adults hospitalized with heart failure, Lee and colleagues found
that early initial outpatient visits with a cardiologist
or general internist within 7 days after discharge was
associated with a 19% lower odds of readmission
[(OR) = 0.81; 95% CI, 0.70–0.94].16 It is possible
that the number of patients is too small to have
shown a statistically significant difference in the secondary outcomes. Physicians and health systems may
be asked to dedicate administrative and cost resources
in order to meet similar discharge metrics, without
knowing if these metrics positively impact the readmission rates in their centers. Further real-world
studies are needed to see if improvements in such
metrics impact readmissions and patient outcomes. In
the meantime, clinicians should continue to strategize
on low-cost pragmatic interventions to increase
patient follow-up.

Conclusions
Ultimately, a standardized discharge scheduling order,
more robust resident education, and a monthly
patient safety and quality award resulted in a significant increase in the rate of primary care follow-up
within 7 days of CHF exacerbation. These results
were achieved without a multidisciplinary team
involved in the discharge ordering or counseling process. Despite significantly more PCP follow-up scheduled and completed within 1 week of discharge, there
was no difference in the rate of 30-day readmission
or mortality. Based on the results of this study, the
authors believe that this protocol is easily applicable
to other teaching institutions without robust clinical
pharmacy and transition of care nursing services who
are asked to meet similar quality metrics for PCP
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follow-up after discharge in CHF exacerbation
patients.
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